British Medical Journal Article Suggests HIV Testing Should No Longer be Accorded Any Special Status

Article

HIV testing should no longer be accorded any special status, argue two senior doctors in this week's British Medical Journal (BMJ). Voluntary HIV counseling and testing has been accepted practice for more than 10 years, but uptake has been poor, even among those at high risk, resulting in late diagnosis and ongoing spread of infection. Unless further initiatives are undertaken the epidemic will worsen, they warn.

 

They believe that HIV testing should be widely accepted, without conventional voluntary counseling and testing, as patients at risk of cancer do not receive voluntary counseling and testing before chest X-rays, or patients with chest infections do not receive voluntary counseling and testing before investigations are carried out.

 

The current combination of a lack of time for pre-test counseling and denial by patients has resulted in late diagnoses and ongoing spread of infection, they say. They propose that if a patient freely consents to be investigated, a doctor can initiate tests aimed at excluding serious diseases without an in-depth discussion of all possible results, provided that the test result, positive or negative, should benefit the patient.

 

Routine voluntary counseling and testing was appropriate to the 1980s, but times have changed and the benefits of early diagnosis of HIV are multiple. HIV testing should now not be accorded any special status. Doctors should now undertake the test by using the same approach as used in any other test with serious implications, they conclude.

 

Source: British Medical Journal

 

 

Recent Videos
Infection Control Today's Infection Intel: Staying Ahead With Company Updates and Product Innovations.
COVID-19 presentations at IDWeek in Las Angeles, California by Invivyd.   (Adobe Stock 333039083 by Production Perig)
Long COVID and Other Post-Viral Syndromes
Meet Jenny Hayes, MSN, RN, CIC, CAIP, CASSPT.
Infection Control Today Editorial Advisory Board: Fibi Attia, MD, MPH, CIC.
Andrea Thomas, PhD, DVM, MSc, BSc, director of epidemiology at BlueDot
mpox   (Adobe Stock 924156809 by Andreas Prott)
Meet Alexander Sundermann, DrPH, CIC, FAPIC.
Veterinary Infection Prevention
Related Content